Privacy settings

Choose whether optional services may connect to their providers. Your choice is stored on this device for up to 180 days. You can change or withdraw it here anytime.

When an optional service is enabled, its provider may receive your IP address and browser information. Read the full privacy and cookie notice and contact details before choosing. Read privacy and cookies · Contact

Ethical investment & sustainable living · since 2010 Sunday 15 November 2026
Ethical Investment and Sustainable Living The Brief

Search Blue & Green Tomorrow

Saved stories

0
Loading saved stories...

Follow Us

Invest
Desk position: Invest, money end

Sex tape starring former executive worsens GSK China corruption scandal

The Invest desk

British pharmaceuticals giant GlaxoSmithKline (GSK) has confirmed one of its former executives does appear in a sex tape – news that places further pressure on a firm already battling allegations of corruption.

A video of the former head of the business’s Chinese operations, Mark Reilly, was emailed to senior executives at GSK. It contained footage of Reilly and his Chinese girlfriend.

Reilly was recently accused of bribing hospital officials to purchase GSK products – which have led to four Chinese GSK executives being arrested and an ongoing international probe into the firm’s operations.

Similar accusations are now being broadcast in Iraq, Poland, Jordan and the Lebanon. The bribery of doctors to prescribe GSK drugs are among the accusations.

The discovery of the video did prompt the hiring of a private investigator, Peter Humphrey, who has now been arrested and accused by Chinese state media, alongside his wife, of selling personal information about clients.

The investigation so far has led to the Chinese accusing GSK of bribing officials through travel agencies and consultancies – spending a total of 3 billion yuan (£323m) on bribes alone.

GSK deny this to be the amount, suggesting it is nowhere near as high.

GSK sales statistics for China fell by 61% last year as the allegations began to gain momentum, apologising for the activities of Chinese employees who were acting outside of its code of conduct.

Earlier this year in May, the Serious Fraud Office (SFO) declared it would be investigating GSK over the bribery accusations the company faces from all over the world.

Photo source: Ian Wilson via Flickr 

Further reading:

GlaxoSmithKline China sales take hit following bribery scandal

GSK faces criminal investigation by fraud office amid bribing scandals

We’ll invest in GlaxoSmithKline for as long as it’s 100% committed to cleaning up its act

Responsible investors react to GlaxoSmithKline bribery allegations

Not financial advice. This article is for general information only and does not take your personal circumstances into account. The value of investments can fall as well as rise. Speak to a regulated financial adviser before making investment decisions.
Found this useful? X LinkedIn
Behind this article

How we put this together

Written by
Blue & Green Tomorrow
Published
Sources
Primary reporting
Standards
About